QAI · Powered Microneedle Device
General, Plastic Surgery · 21 CFR 878.4430 · Class 2
Overview
| Product Code | QAI |
|---|---|
| Device Name | Powered Microneedle Device |
| Regulation | 21 CFR 878.4430 |
| Device Class | Class 2 |
| Review Panel | General, Plastic Surgery |
Identification
A microneedling device for aesthetic use is a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use. This classification does not include devices intended for transdermal delivery of topical products such as cosmetics, drugs, or biologics.
Classification Rationale
Class II (special controls). The special controls for this device are:
Special Controls
The technical specifications and needle characteristics must be identified, including needle length, geometry, maximum penetration depth, and puncture rate. Non-clinical performance data must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested: (i) Accuracy of needle penetration depth and puncture rate; (ii) Safety features built into the device to protect against cross-contamination, including fluid ingress protection; and (iii) Identification of the maximum safe needle penetration depth for the device for the labeled indications for use. Performance data must demonstrate the sterility of the patient-contacting components of the device. Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the intended shelf life. Performance data must demonstrate the electrical safety and electromagnetic compatibility (EMC) of all electrical components of the device. Software verification, validation, and hazard analysis must be performed for all software components of the device. The patient-contacting components of the device must be demonstrated to be biocompatible. Performance data must validate the cleaning and disinfection instructions for reusable components of the device. Labeling must include the following: (i) Information on how to operate the device and its components and the typical course of treatment; (ii) A summary of the device technical parameters, including needle length, needle geometry, maximum penetration depth, and puncture rate; (iii) Validated methods and instructions for reprocessing of any reusable components: (iv) Disposal instructions; and (v) Shelf life. Patient labeling must be provided and must include: (i) Information on how the device operates and the typical course of treatment; (ii) The probable risks and benefits associated with use of the device; and (iii) Post-operative care instructions.
*Classification.* Class II (special controls). The special controls for this device are:(1) The technical specifications and needle characteristics must be identified, including needle length, geometry, maximum penetration depth, and puncture rate. (2) Non-clinical performance data must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested: (i) Accuracy of needle penetration depth and puncture rate; (ii) Safety features built into the device to protect against cross-contamination, including fluid ingress protection; and (iii) Identification of the maximum safe needle penetration depth for the device for the labeled indications for use. (3) Performance data must demonstrate the sterility of the patient-contacting components of the device. (4) Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the intended shelf life. (5) Performance data must demonstrate the electrical safety and electromagnetic compatibility (EMC) of all electrical components of the device. (6) Software verification, validation, and hazard analysis must be performed for all software components of the device. (7) The patient-contacting components of the device must be demonstrated to be biocompatible. (8) Performance data must validate the cleaning and disinfection instructions for reusable components of the device. (9) Labeling must include the following: (i) Information on how to operate the device and its components and the typical course of treatment; (ii) A summary of the device technical parameters, including needle length, needle geometry, maximum penetration depth, and puncture rate; (iii) Validated methods and instructions for reprocessing of any reusable components; (iv) Disposal instructions; and (v) A shelf life. (10) Patient labeling must be provided and must include: (i) Information on how the device operates and the typical course of treatment; (ii) The probable risks and benefits associated with use of the device; and (iii) Postoperative care instructions.
Cleared Devices (25)
| Record | Device Name | Applicant | Decision Date | Decision |
|---|---|---|---|---|
| K253002 | SkinStylus SteriLock MicroSystem (MP1209SL) | Esthetic Medical, Inc. | Feb 19, 2026 | SESE |
| K252752 | ellacor System with Micro-Coring Technology | Cytrellis Biosystems, Inc. | Oct 30, 2025 | SESE |
| K253153 | SER Pen Carain MicroSystem (MP1209SP) | Su-Ko Technologies, LLC | Oct 29, 2025 | SESE |
| K243800 | PRO Pen Microneedling System (6883) | Dermalogica, LLC | Aug 25, 2025 | SESE |
| K243143 | E-PEN (E-PEN) | Bomtech Electronics Co., Ltd. | Apr 7, 2025 | SESE |
| K243472 | 1NEED Pro | Campomats S.R.L. | Mar 19, 2025 | SESE |
| K241790 | XCELLARISPRO TWIST microneedling device | Dermaroller GmbH | Mar 6, 2025 | SESE |
| K241355 | SER Pen Carain MicroSystem (MP1209SP) | Su-Ko Technologies, LLC | Oct 9, 2024 | SESE |
| K241400 | SkinPen Precision Elite System | Crown Aesthetics | Aug 29, 2024 | SESE |
| K233709 | Exceed Unlimited | Mt. Derm GmbH | Feb 23, 2024 | SESE |
| K230420 | Dr. pen Microneedling System | Guangzhou Ekai Electronic Technology Co., Ltd. | Aug 11, 2023 | SESE |
| K231073 | SkinStylus SteriLock® MicroSystem, Model Number MP1209SL | Esthetic Medical, Inc. | Jul 28, 2023 | SESE |
| K221070 | DP4 Microneedling device | Equipmed USA, LLC | Dec 20, 2022 | SESE |
| K221011 | AI.ME System | Venus Concept USA, Inc. | Dec 20, 2022 | SESE |
| K222199 | Collagen P.I.N. (Percutaneous Induction Needling) | Induction Therapies, LLC | Oct 21, 2022 | SESE |
| K220506 | SkinPen Precision System | Crown Aesthetics | Mar 7, 2022 | SESE |
| K212558 | MicroPen EVO | Eclipse Medcorp, LLC | Nov 24, 2021 | SESE |
| K202517 | Cytrellis Dermal Micro-Coring System | Cytrellis Biosystems, Inc. | Jul 9, 2021 | SESE |
| K203144 | MicroPen EVO | Eclipse Medcorp, LLC | May 25, 2021 | SESE |
| K202243 | SkinPen Precision System | Crown Aesthetics | Apr 2, 2021 | SESE |
| K200044 | SkinStylus SteriLock MicroSystem | Esthetic Education, LLC | Apr 10, 2020 | SESE |
| K192138 | Rejuvapen NXT | Refine USA, LLC | Apr 9, 2020 | SESE |
| K182407 | Exceed Microneedling device | Mt. Derm GmbH | Jul 19, 2019 | SESE |
| K180778 | Exceed Microneedling Device | Mt. Derm GmbH | Sep 7, 2018 | SESE |
| DEN160029 | SkinPen Precision System | Bellus Medical, LLC | Mar 1, 2018 | DENG |
Top Applicants
- Mt. Derm GmbH — 3 clearances
- Crown Aesthetics — 3 clearances
- Su-Ko Technologies, LLC — 2 clearances
- Esthetic Medical, Inc. — 2 clearances
- Eclipse Medcorp, LLC — 2 clearances